Compare · GEHC vs NNOX
GEHC vs NNOX
Side-by-side comparison of GE HealthCare Technologies Inc. (GEHC) and NANO-X IMAGING LTD (NNOX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GEHC and NNOX operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $27.76B, about 230.6x NNOX ($120.4M).
- GEHC has been more active in the news (14 items in the past 4 weeks vs 12 for NNOX).
- GEHC has more recent analyst coverage (25 ratings vs 3 for NNOX).
- Company
- GE HealthCare Technologies Inc.
- NANO-X IMAGING LTD
- Price
- -
- -
- Market cap
- $27.76B
- $120.4M
- 1M return
- -15.21%
- -
- 1Y return
- -13.46%
- -
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 14
- 12
- Recent ratings
- 25
- 3
NANO-X IMAGING LTD
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
Latest GEHC
- Chief Financial Officer Saccaro James bought $200,585 worth of shares (3,310 units at $60.60), increasing direct ownership by 4% to 87,471 units (SEC Form 4)
- GC & Corporate Secretary Jimenez Frank R bought $105,788 worth of shares (1,750 units at $60.45), increasing direct ownership by 2% to 93,932 units (SEC Form 4)
- President and CEO Arduini Peter J bought $249,827 worth of shares (4,169 units at $59.92), increasing direct ownership by 2% to 259,424 units (SEC Form 4)
- GE HealthCare downgraded by Goldman with a new price target
- SEC Form 10-Q filed by GE HealthCare Technologies Inc.
- GE HealthCare Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GE HealthCare reports first quarter 2026 financial results
- GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth
- GE HealthCare management to present at upcoming investor conferences
- GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents
Latest NNOX
- SEC Form 20-F filed by NANO-X IMAGING LTD
- New insider Suesskind Dan S claimed ownership of 25,336 units of Ordinary shares (SEC Form 3)
- Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States
- Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years
- SEC Form 6-K filed by NANO-X IMAGING LTD
- Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates
- Nanox Announces Collaboration with Meir Medical Center to Deploy Nanox.ARC for Orthopedic Imaging Clinical Study
- Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas
- SEC Form 3 filed by new insider Yahav Attias Gali
- SEC Form 3 filed by new insider Saban Sharon